nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—breast cancer	0.246	1	CbGaD
Sibutramine—CYP3A4—Exemestane—breast cancer	0.0516	0.133	CbGbCtD
Sibutramine—CYP3A4—Letrozole—breast cancer	0.0438	0.113	CbGbCtD
Sibutramine—CYP3A4—Anastrozole—breast cancer	0.0391	0.101	CbGbCtD
Sibutramine—CYP3A4—Toremifene—breast cancer	0.0357	0.0921	CbGbCtD
Sibutramine—CYP3A4—Fulvestrant—breast cancer	0.0332	0.0856	CbGbCtD
Sibutramine—CYP3A4—Thiotepa—breast cancer	0.0296	0.0763	CbGbCtD
Sibutramine—CYP3A4—Ixabepilone—breast cancer	0.0271	0.0698	CbGbCtD
Sibutramine—CYP3A4—Lapatinib—breast cancer	0.0261	0.0672	CbGbCtD
Sibutramine—CYP3A4—Raloxifene—breast cancer	0.0198	0.0509	CbGbCtD
Sibutramine—CYP3A4—Vinorelbine—breast cancer	0.0145	0.0373	CbGbCtD
Sibutramine—CYP3A4—Tamoxifen—breast cancer	0.0131	0.0336	CbGbCtD
Sibutramine—CYP3A4—Mitoxantrone—breast cancer	0.0127	0.0328	CbGbCtD
Sibutramine—CYP3A4—Paclitaxel—breast cancer	0.0102	0.0262	CbGbCtD
Sibutramine—CYP3A4—Irinotecan—breast cancer	0.01	0.0258	CbGbCtD
Sibutramine—CYP3A4—Vinblastine—breast cancer	0.00891	0.023	CbGbCtD
Sibutramine—CYP3A4—Docetaxel—breast cancer	0.00734	0.0189	CbGbCtD
Sibutramine—CYP3A4—Doxorubicin—breast cancer	0.00548	0.0141	CbGbCtD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—breast cancer	0.000105	0.00179	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTP1—breast cancer	0.000105	0.00179	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—TGFBR2—breast cancer	0.000105	0.00179	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—HSP90AA1—breast cancer	0.000104	0.00179	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000104	0.00178	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—ACHE—breast cancer	0.000104	0.00178	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—EGR1—breast cancer	0.000103	0.00177	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—HMOX1—breast cancer	0.000103	0.00177	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000102	0.00175	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000101	0.00172	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—COX11—breast cancer	0.000101	0.00172	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.0001	0.00171	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.0001	0.00171	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—HGF—breast cancer	9.61e-05	0.00164	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTM1—breast cancer	9.61e-05	0.00164	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—NRG1—breast cancer	9.43e-05	0.00161	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—TGFBR2—breast cancer	9.26e-05	0.00159	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTP1—breast cancer	9.26e-05	0.00159	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC22A18—breast cancer	9.21e-05	0.00158	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—HMOX1—breast cancer	9.13e-05	0.00156	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—BCHE—breast cancer	9.05e-05	0.00155	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—breast cancer	9.04e-05	0.00155	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC2A2—breast cancer	9.04e-05	0.00155	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—SIRT1—breast cancer	9.02e-05	0.00154	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—breast cancer	8.93e-05	0.00153	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLCO1B1—breast cancer	8.87e-05	0.00152	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC2A5—breast cancer	8.87e-05	0.00152	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CHST9—breast cancer	8.79e-05	0.0015	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—TYMS—breast cancer	8.75e-05	0.0015	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NCOR1—breast cancer	8.65e-05	0.00148	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	8.62e-05	0.00148	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—breast cancer	8.61e-05	0.00147	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—breast cancer	8.6e-05	0.00147	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTM1—breast cancer	8.51e-05	0.00146	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—HGF—breast cancer	8.51e-05	0.00146	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—NRG1—breast cancer	8.35e-05	0.00143	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP1B1—breast cancer	8.21e-05	0.00141	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	8.18e-05	0.0014	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—ACHE—breast cancer	7.96e-05	0.00136	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	7.9e-05	0.00135	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—breast cancer	7.89e-05	0.00135	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ATP7B—breast cancer	7.88e-05	0.00135	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—breast cancer	7.79e-05	0.00133	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP19A1—breast cancer	7.72e-05	0.00132	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—breast cancer	7.66e-05	0.00131	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC39A6—breast cancer	7.63e-05	0.00131	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—breast cancer	7.56e-05	0.00129	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—breast cancer	7.52e-05	0.00129	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCC1—breast cancer	7.33e-05	0.00125	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—breast cancer	7.25e-05	0.00124	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—COMT—breast cancer	7.23e-05	0.00124	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—LEP—breast cancer	7.12e-05	0.00122	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—breast cancer	7e-05	0.0012	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ATP7B—breast cancer	6.98e-05	0.0012	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—BCHE—breast cancer	6.93e-05	0.00119	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—CDK4—breast cancer	6.82e-05	0.00117	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	6.64e-05	0.00114	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NOS2—breast cancer	6.63e-05	0.00114	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—breast cancer	6.55e-05	0.00112	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCC1—breast cancer	6.49e-05	0.00111	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	6.4e-05	0.00109	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	6.34e-05	0.00108	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	6.33e-05	0.00108	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	6.24e-05	0.00107	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—TUBB3—breast cancer	6.23e-05	0.00107	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP1A1—breast cancer	6.22e-05	0.00107	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	6.21e-05	0.00106	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—breast cancer	6.16e-05	0.00105	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—ALDH1A1—breast cancer	6.11e-05	0.00105	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	6.09e-05	0.00104	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—breast cancer	5.79e-05	0.000992	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—SERPINE1—breast cancer	5.59e-05	0.000956	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL1B—breast cancer	5.56e-05	0.000951	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CASP3—breast cancer	5.54e-05	0.000949	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—COMT—breast cancer	5.54e-05	0.000949	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—TUBB3—breast cancer	5.52e-05	0.000945	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTA3—breast cancer	5.44e-05	0.000932	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—JUN—breast cancer	5.39e-05	0.000922	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	5.38e-05	0.000922	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTA3—breast cancer	5.37e-05	0.000919	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—breast cancer	5.34e-05	0.000915	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	5.18e-05	0.000887	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	5.14e-05	0.000879	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCG2—breast cancer	5.08e-05	0.000869	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	5.06e-05	0.000867	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	5.03e-05	0.000862	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTA4—breast cancer	4.98e-05	0.000852	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	4.97e-05	0.00085	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	4.91e-05	0.000841	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTA2—breast cancer	4.85e-05	0.000831	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—SULT1A1—breast cancer	4.79e-05	0.00082	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	4.79e-05	0.000819	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	4.73e-05	0.000809	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	4.73e-05	0.000809	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—breast cancer	4.71e-05	0.000805	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTA1—breast cancer	4.68e-05	0.000801	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—NAT2—breast cancer	4.63e-05	0.000792	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—BRAF—breast cancer	4.62e-05	0.000791	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC2A2—breast cancer	4.59e-05	0.000786	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	4.57e-05	0.000782	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—TGFB1—breast cancer	4.55e-05	0.00078	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—TFRC—breast cancer	4.53e-05	0.000775	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCG2—breast cancer	4.5e-05	0.00077	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—JUN—breast cancer	4.4e-05	0.000753	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—NCOA2—breast cancer	4.36e-05	0.000746	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PTEN—breast cancer	4.25e-05	0.000728	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—MAPK8—breast cancer	4.16e-05	0.000712	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	4.16e-05	0.000712	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	4.08e-05	0.000698	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TNF—breast cancer	4.03e-05	0.00069	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	4.01e-05	0.000687	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—TFRC—breast cancer	4.01e-05	0.000686	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—TGFB1—breast cancer	3.92e-05	0.00067	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—ALB—breast cancer	3.9e-05	0.000668	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—MDM2—breast cancer	3.87e-05	0.000662	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—NCOA2—breast cancer	3.86e-05	0.000661	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—RAF1—breast cancer	3.86e-05	0.00066	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	3.84e-05	0.000657	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—MTR—breast cancer	3.77e-05	0.000646	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—HPGDS—breast cancer	3.7e-05	0.000633	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.68e-05	0.00063	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—NCOA1—breast cancer	3.67e-05	0.000629	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTT1—breast cancer	3.59e-05	0.000614	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—PLG—breast cancer	3.58e-05	0.000613	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.56e-05	0.000609	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—BRAF—breast cancer	3.54e-05	0.000606	CbGpPWpGaD
Sibutramine—Headache—Gemcitabine—breast cancer	3.52e-05	0.000114	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Capecitabine—breast cancer	3.52e-05	0.000114	CcSEcCtD
Sibutramine—Vomiting—Fluorouracil—breast cancer	3.51e-05	0.000114	CcSEcCtD
Sibutramine—Rhinitis—Doxorubicin—breast cancer	3.51e-05	0.000114	CcSEcCtD
Sibutramine—Dyspepsia—Docetaxel—breast cancer	3.51e-05	0.000114	CcSEcCtD
Sibutramine—Haemorrhage—Doxorubicin—breast cancer	3.5e-05	0.000114	CcSEcCtD
Sibutramine—Insomnia—Capecitabine—breast cancer	3.49e-05	0.000114	CcSEcCtD
Sibutramine—Hypoaesthesia—Doxorubicin—breast cancer	3.48e-05	0.000113	CcSEcCtD
Sibutramine—Rash—Fluorouracil—breast cancer	3.48e-05	0.000113	CcSEcCtD
Sibutramine—Dermatitis—Fluorouracil—breast cancer	3.48e-05	0.000113	CcSEcCtD
Sibutramine—Pharyngitis—Doxorubicin—breast cancer	3.47e-05	0.000113	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—TGFB1—breast cancer	3.47e-05	0.000594	CbGpPWpGaD
Sibutramine—Paraesthesia—Capecitabine—breast cancer	3.46e-05	0.000113	CcSEcCtD
Sibutramine—Decreased appetite—Docetaxel—breast cancer	3.46e-05	0.000113	CcSEcCtD
Sibutramine—Hypersensitivity—Paclitaxel—breast cancer	3.46e-05	0.000113	CcSEcCtD
Sibutramine—Headache—Fluorouracil—breast cancer	3.46e-05	0.000113	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—ALB—breast cancer	3.46e-05	0.000592	CbGpPWpGaD
Sibutramine—Oedema peripheral—Doxorubicin—breast cancer	3.45e-05	0.000112	CcSEcCtD
Sibutramine—Dysgeusia—Methotrexate—breast cancer	3.45e-05	0.000112	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Docetaxel—breast cancer	3.44e-05	0.000112	CcSEcCtD
Sibutramine—Dyspnoea—Capecitabine—breast cancer	3.44e-05	0.000112	CcSEcCtD
Sibutramine—Angiopathy—Epirubicin—breast cancer	3.43e-05	0.000112	CcSEcCtD
Sibutramine—Nausea—Irinotecan—breast cancer	3.42e-05	0.000111	CcSEcCtD
Sibutramine—Nausea—Mitoxantrone—breast cancer	3.42e-05	0.000111	CcSEcCtD
Sibutramine—Immune system disorder—Epirubicin—breast cancer	3.42e-05	0.000111	CcSEcCtD
Sibutramine—Constipation—Docetaxel—breast cancer	3.41e-05	0.000111	CcSEcCtD
Sibutramine—Pain—Docetaxel—breast cancer	3.41e-05	0.000111	CcSEcCtD
Sibutramine—Back pain—Methotrexate—breast cancer	3.4e-05	0.000111	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—CYP17A1—breast cancer	3.4e-05	0.000582	CbGpPWpGaD
Sibutramine—Dyspepsia—Capecitabine—breast cancer	3.4e-05	0.000111	CcSEcCtD
Sibutramine—Chills—Epirubicin—breast cancer	3.39e-05	0.00011	CcSEcCtD
Sibutramine—Arrhythmia—Epirubicin—breast cancer	3.38e-05	0.00011	CcSEcCtD
Sibutramine—Visual impairment—Doxorubicin—breast cancer	3.37e-05	0.00011	CcSEcCtD
Sibutramine—Asthenia—Paclitaxel—breast cancer	3.37e-05	0.00011	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—PTGS1—breast cancer	3.36e-05	0.000576	CbGpPWpGaD
Sibutramine—Decreased appetite—Capecitabine—breast cancer	3.35e-05	0.000109	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	3.35e-05	0.000574	CbGpPWpGaD
Sibutramine—Alopecia—Epirubicin—breast cancer	3.34e-05	0.000109	CcSEcCtD
Sibutramine—Nausea—Gemcitabine—breast cancer	3.34e-05	0.000109	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Capecitabine—breast cancer	3.33e-05	0.000108	CcSEcCtD
Sibutramine—Pruritus—Paclitaxel—breast cancer	3.33e-05	0.000108	CcSEcCtD
Sibutramine—Vision blurred—Methotrexate—breast cancer	3.32e-05	0.000108	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—HMOX1—breast cancer	3.3e-05	0.000565	CbGpPWpGaD
Sibutramine—Constipation—Capecitabine—breast cancer	3.3e-05	0.000107	CcSEcCtD
Sibutramine—Pain—Capecitabine—breast cancer	3.3e-05	0.000107	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—CYP2D6—breast cancer	3.3e-05	0.000565	CbGpPWpGaD
Sibutramine—Malnutrition—Epirubicin—breast cancer	3.29e-05	0.000107	CcSEcCtD
Sibutramine—Feeling abnormal—Docetaxel—breast cancer	3.28e-05	0.000107	CcSEcCtD
Sibutramine—Nausea—Fluorouracil—breast cancer	3.28e-05	0.000107	CcSEcCtD
Sibutramine—Eye disorder—Doxorubicin—breast cancer	3.27e-05	0.000106	CcSEcCtD
Sibutramine—Ill-defined disorder—Methotrexate—breast cancer	3.27e-05	0.000106	CcSEcCtD
Sibutramine—Tinnitus—Doxorubicin—breast cancer	3.26e-05	0.000106	CcSEcCtD
Sibutramine—Gastrointestinal pain—Docetaxel—breast cancer	3.26e-05	0.000106	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6—breast cancer	3.25e-05	0.000557	CbGpPWpGaD
Sibutramine—Anaemia—Methotrexate—breast cancer	3.25e-05	0.000106	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	3.25e-05	0.000557	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—NCOA1—breast cancer	3.25e-05	0.000557	CbGpPWpGaD
Sibutramine—Flatulence—Epirubicin—breast cancer	3.25e-05	0.000106	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—NCOA2—breast cancer	3.24e-05	0.000554	CbGpPWpGaD
Sibutramine—Tension—Epirubicin—breast cancer	3.23e-05	0.000105	CcSEcCtD
Sibutramine—Dysgeusia—Epirubicin—breast cancer	3.23e-05	0.000105	CcSEcCtD
Sibutramine—Diarrhoea—Paclitaxel—breast cancer	3.22e-05	0.000105	CcSEcCtD
Sibutramine—Nervousness—Epirubicin—breast cancer	3.2e-05	0.000104	CcSEcCtD
Sibutramine—Back pain—Epirubicin—breast cancer	3.19e-05	0.000104	CcSEcCtD
Sibutramine—Feeling abnormal—Capecitabine—breast cancer	3.18e-05	0.000103	CcSEcCtD
Sibutramine—Angiopathy—Doxorubicin—breast cancer	3.18e-05	0.000103	CcSEcCtD
Sibutramine—Malaise—Methotrexate—breast cancer	3.17e-05	0.000103	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—PLG—breast cancer	3.17e-05	0.000543	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCB1—breast cancer	3.17e-05	0.000543	CbGpPWpGaD
Sibutramine—Muscle spasms—Epirubicin—breast cancer	3.17e-05	0.000103	CcSEcCtD
Sibutramine—Immune system disorder—Doxorubicin—breast cancer	3.16e-05	0.000103	CcSEcCtD
Sibutramine—Vertigo—Methotrexate—breast cancer	3.16e-05	0.000103	CcSEcCtD
Sibutramine—Gastrointestinal pain—Capecitabine—breast cancer	3.16e-05	0.000103	CcSEcCtD
Sibutramine—Abdominal pain—Docetaxel—breast cancer	3.15e-05	0.000103	CcSEcCtD
Sibutramine—Body temperature increased—Docetaxel—breast cancer	3.15e-05	0.000103	CcSEcCtD
Sibutramine—Leukopenia—Methotrexate—breast cancer	3.15e-05	0.000103	CcSEcCtD
Sibutramine—Chills—Doxorubicin—breast cancer	3.14e-05	0.000102	CcSEcCtD
Sibutramine—Arrhythmia—Doxorubicin—breast cancer	3.13e-05	0.000102	CcSEcCtD
Sibutramine—Dizziness—Paclitaxel—breast cancer	3.11e-05	0.000101	CcSEcCtD
Sibutramine—Vision blurred—Epirubicin—breast cancer	3.1e-05	0.000101	CcSEcCtD
Sibutramine—Alopecia—Doxorubicin—breast cancer	3.09e-05	0.000101	CcSEcCtD
Sibutramine—Cough—Methotrexate—breast cancer	3.07e-05	9.99e-05	CcSEcCtD
Sibutramine—Urticaria—Capecitabine—breast cancer	3.07e-05	9.98e-05	CcSEcCtD
Sibutramine—Ill-defined disorder—Epirubicin—breast cancer	3.06e-05	9.95e-05	CcSEcCtD
Sibutramine—Body temperature increased—Capecitabine—breast cancer	3.05e-05	9.93e-05	CcSEcCtD
Sibutramine—Abdominal pain—Capecitabine—breast cancer	3.05e-05	9.93e-05	CcSEcCtD
Sibutramine—Convulsion—Methotrexate—breast cancer	3.05e-05	9.92e-05	CcSEcCtD
Sibutramine—Malnutrition—Doxorubicin—breast cancer	3.05e-05	9.92e-05	CcSEcCtD
Sibutramine—Anaemia—Epirubicin—breast cancer	3.04e-05	9.91e-05	CcSEcCtD
Sibutramine—Agitation—Epirubicin—breast cancer	3.03e-05	9.85e-05	CcSEcCtD
Sibutramine—Flatulence—Doxorubicin—breast cancer	3e-05	9.77e-05	CcSEcCtD
Sibutramine—Arthralgia—Methotrexate—breast cancer	3e-05	9.75e-05	CcSEcCtD
Sibutramine—Chest pain—Methotrexate—breast cancer	3e-05	9.75e-05	CcSEcCtD
Sibutramine—Myalgia—Methotrexate—breast cancer	3e-05	9.75e-05	CcSEcCtD
Sibutramine—Tension—Doxorubicin—breast cancer	2.99e-05	9.73e-05	CcSEcCtD
Sibutramine—Vomiting—Paclitaxel—breast cancer	2.99e-05	9.73e-05	CcSEcCtD
Sibutramine—Dysgeusia—Doxorubicin—breast cancer	2.98e-05	9.71e-05	CcSEcCtD
Sibutramine—Malaise—Epirubicin—breast cancer	2.97e-05	9.67e-05	CcSEcCtD
Sibutramine—Rash—Paclitaxel—breast cancer	2.96e-05	9.65e-05	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—MDM2—breast cancer	2.96e-05	0.000508	CbGpPWpGaD
Sibutramine—Dermatitis—Paclitaxel—breast cancer	2.96e-05	9.64e-05	CcSEcCtD
Sibutramine—Discomfort—Methotrexate—breast cancer	2.96e-05	9.63e-05	CcSEcCtD
Sibutramine—Nervousness—Doxorubicin—breast cancer	2.96e-05	9.63e-05	CcSEcCtD
Sibutramine—Vertigo—Epirubicin—breast cancer	2.96e-05	9.63e-05	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—RAF1—breast cancer	2.95e-05	0.000506	CbGpPWpGaD
Sibutramine—Syncope—Epirubicin—breast cancer	2.95e-05	9.61e-05	CcSEcCtD
Sibutramine—Leukopenia—Epirubicin—breast cancer	2.95e-05	9.59e-05	CcSEcCtD
Sibutramine—Back pain—Doxorubicin—breast cancer	2.95e-05	9.59e-05	CcSEcCtD
Sibutramine—Headache—Paclitaxel—breast cancer	2.95e-05	9.59e-05	CcSEcCtD
Sibutramine—Hypersensitivity—Docetaxel—breast cancer	2.94e-05	9.56e-05	CcSEcCtD
Sibutramine—Muscle spasms—Doxorubicin—breast cancer	2.93e-05	9.54e-05	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—HMOX1—breast cancer	2.93e-05	0.000501	CbGpPWpGaD
Sibutramine—Palpitations—Epirubicin—breast cancer	2.91e-05	9.47e-05	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—TP53—breast cancer	2.9e-05	0.000497	CbGpPWpGaD
Sibutramine—Confusional state—Methotrexate—breast cancer	2.9e-05	9.43e-05	CcSEcCtD
Sibutramine—Loss of consciousness—Epirubicin—breast cancer	2.89e-05	9.42e-05	CcSEcCtD
Sibutramine—Cough—Epirubicin—breast cancer	2.87e-05	9.35e-05	CcSEcCtD
Sibutramine—Anaphylactic shock—Methotrexate—breast cancer	2.87e-05	9.35e-05	CcSEcCtD
Sibutramine—Vision blurred—Doxorubicin—breast cancer	2.87e-05	9.35e-05	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—CYP1B1—breast cancer	2.86e-05	0.00049	CbGpPWpGaD
Sibutramine—Asthenia—Docetaxel—breast cancer	2.86e-05	9.31e-05	CcSEcCtD
Sibutramine—Convulsion—Epirubicin—breast cancer	2.85e-05	9.29e-05	CcSEcCtD
Sibutramine—Infection—Methotrexate—breast cancer	2.85e-05	9.29e-05	CcSEcCtD
Sibutramine—Hypertension—Epirubicin—breast cancer	2.84e-05	9.25e-05	CcSEcCtD
Sibutramine—Hypersensitivity—Capecitabine—breast cancer	2.84e-05	9.25e-05	CcSEcCtD
Sibutramine—Ill-defined disorder—Doxorubicin—breast cancer	2.83e-05	9.2e-05	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	2.82e-05	0.000483	CbGpPWpGaD
Sibutramine—Pruritus—Docetaxel—breast cancer	2.82e-05	9.18e-05	CcSEcCtD
Sibutramine—Anaemia—Doxorubicin—breast cancer	2.82e-05	9.17e-05	CcSEcCtD
Sibutramine—Thrombocytopenia—Methotrexate—breast cancer	2.81e-05	9.15e-05	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCB1—breast cancer	2.81e-05	0.000481	CbGpPWpGaD
Sibutramine—Chest pain—Epirubicin—breast cancer	2.8e-05	9.13e-05	CcSEcCtD
Sibutramine—Arthralgia—Epirubicin—breast cancer	2.8e-05	9.13e-05	CcSEcCtD
Sibutramine—Myalgia—Epirubicin—breast cancer	2.8e-05	9.13e-05	CcSEcCtD
Sibutramine—Agitation—Doxorubicin—breast cancer	2.8e-05	9.11e-05	CcSEcCtD
Sibutramine—Anxiety—Epirubicin—breast cancer	2.79e-05	9.09e-05	CcSEcCtD
Sibutramine—Nausea—Paclitaxel—breast cancer	2.79e-05	9.09e-05	CcSEcCtD
Sibutramine—Skin disorder—Methotrexate—breast cancer	2.79e-05	9.08e-05	CcSEcCtD
Sibutramine—Hyperhidrosis—Methotrexate—breast cancer	2.78e-05	9.04e-05	CcSEcCtD
Sibutramine—Discomfort—Epirubicin—breast cancer	2.77e-05	9.02e-05	CcSEcCtD
Sibutramine—Asthenia—Capecitabine—breast cancer	2.77e-05	9.01e-05	CcSEcCtD
Sibutramine—Malaise—Doxorubicin—breast cancer	2.75e-05	8.94e-05	CcSEcCtD
Sibutramine—Dry mouth—Epirubicin—breast cancer	2.74e-05	8.92e-05	CcSEcCtD
Sibutramine—Vertigo—Doxorubicin—breast cancer	2.74e-05	8.91e-05	CcSEcCtD
Sibutramine—Anorexia—Methotrexate—breast cancer	2.74e-05	8.91e-05	CcSEcCtD
Sibutramine—Syncope—Doxorubicin—breast cancer	2.73e-05	8.89e-05	CcSEcCtD
Sibutramine—Pruritus—Capecitabine—breast cancer	2.73e-05	8.88e-05	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.73e-05	0.000467	CbGpPWpGaD
Sibutramine—Leukopenia—Doxorubicin—breast cancer	2.73e-05	8.88e-05	CcSEcCtD
Sibutramine—Diarrhoea—Docetaxel—breast cancer	2.73e-05	8.87e-05	CcSEcCtD
Sibutramine—Confusional state—Epirubicin—breast cancer	2.71e-05	8.82e-05	CcSEcCtD
Sibutramine—Palpitations—Doxorubicin—breast cancer	2.69e-05	8.76e-05	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2.69e-05	0.00046	CbGpPWpGaD
Sibutramine—Oedema—Epirubicin—breast cancer	2.69e-05	8.75e-05	CcSEcCtD
Sibutramine—Anaphylactic shock—Epirubicin—breast cancer	2.69e-05	8.75e-05	CcSEcCtD
Sibutramine—Hypotension—Methotrexate—breast cancer	2.68e-05	8.73e-05	CcSEcCtD
Sibutramine—Loss of consciousness—Doxorubicin—breast cancer	2.68e-05	8.72e-05	CcSEcCtD
Sibutramine—Infection—Epirubicin—breast cancer	2.67e-05	8.69e-05	CcSEcCtD
Sibutramine—Cough—Doxorubicin—breast cancer	2.66e-05	8.65e-05	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—IL6—breast cancer	2.66e-05	0.000455	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	2.65e-05	0.000454	CbGpPWpGaD
Sibutramine—Shock—Epirubicin—breast cancer	2.64e-05	8.61e-05	CcSEcCtD
Sibutramine—Convulsion—Doxorubicin—breast cancer	2.64e-05	8.59e-05	CcSEcCtD
Sibutramine—Diarrhoea—Capecitabine—breast cancer	2.64e-05	8.59e-05	CcSEcCtD
Sibutramine—Dizziness—Docetaxel—breast cancer	2.64e-05	8.58e-05	CcSEcCtD
Sibutramine—Thrombocytopenia—Epirubicin—breast cancer	2.63e-05	8.57e-05	CcSEcCtD
Sibutramine—Hypertension—Doxorubicin—breast cancer	2.63e-05	8.56e-05	CcSEcCtD
Sibutramine—Tachycardia—Epirubicin—breast cancer	2.62e-05	8.54e-05	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Methotrexate—breast cancer	2.62e-05	8.52e-05	CcSEcCtD
Sibutramine—Skin disorder—Epirubicin—breast cancer	2.61e-05	8.5e-05	CcSEcCtD
Sibutramine—Hyperhidrosis—Epirubicin—breast cancer	2.6e-05	8.46e-05	CcSEcCtD
Sibutramine—Insomnia—Methotrexate—breast cancer	2.6e-05	8.45e-05	CcSEcCtD
Sibutramine—Myalgia—Doxorubicin—breast cancer	2.59e-05	8.44e-05	CcSEcCtD
Sibutramine—Arthralgia—Doxorubicin—breast cancer	2.59e-05	8.44e-05	CcSEcCtD
Sibutramine—Chest pain—Doxorubicin—breast cancer	2.59e-05	8.44e-05	CcSEcCtD
Sibutramine—Anxiety—Doxorubicin—breast cancer	2.59e-05	8.41e-05	CcSEcCtD
Sibutramine—Paraesthesia—Methotrexate—breast cancer	2.58e-05	8.39e-05	CcSEcCtD
Sibutramine—Discomfort—Doxorubicin—breast cancer	2.56e-05	8.34e-05	CcSEcCtD
Sibutramine—Anorexia—Epirubicin—breast cancer	2.56e-05	8.34e-05	CcSEcCtD
Sibutramine—Dyspnoea—Methotrexate—breast cancer	2.56e-05	8.33e-05	CcSEcCtD
Sibutramine—Somnolence—Methotrexate—breast cancer	2.55e-05	8.31e-05	CcSEcCtD
Sibutramine—Dizziness—Capecitabine—breast cancer	2.55e-05	8.3e-05	CcSEcCtD
Sibutramine—Dry mouth—Doxorubicin—breast cancer	2.54e-05	8.26e-05	CcSEcCtD
Sibutramine—Vomiting—Docetaxel—breast cancer	2.53e-05	8.25e-05	CcSEcCtD
Sibutramine—Dyspepsia—Methotrexate—breast cancer	2.53e-05	8.23e-05	CcSEcCtD
Sibutramine—Rash—Docetaxel—breast cancer	2.51e-05	8.18e-05	CcSEcCtD
Sibutramine—Hypotension—Epirubicin—breast cancer	2.51e-05	8.17e-05	CcSEcCtD
Sibutramine—Dermatitis—Docetaxel—breast cancer	2.51e-05	8.17e-05	CcSEcCtD
Sibutramine—Confusional state—Doxorubicin—breast cancer	2.51e-05	8.16e-05	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—COMT—breast cancer	2.5e-05	0.000428	CbGpPWpGaD
Sibutramine—Decreased appetite—Methotrexate—breast cancer	2.5e-05	8.13e-05	CcSEcCtD
Sibutramine—Headache—Docetaxel—breast cancer	2.5e-05	8.13e-05	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.49e-05	0.000426	CbGpPWpGaD
Sibutramine—Anaphylactic shock—Doxorubicin—breast cancer	2.49e-05	8.09e-05	CcSEcCtD
Sibutramine—Oedema—Doxorubicin—breast cancer	2.49e-05	8.09e-05	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Methotrexate—breast cancer	2.48e-05	8.07e-05	CcSEcCtD
Sibutramine—Infection—Doxorubicin—breast cancer	2.47e-05	8.04e-05	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.47e-05	0.000422	CbGpPWpGaD
Sibutramine—Pain—Methotrexate—breast cancer	2.46e-05	7.99e-05	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.45e-05	0.00042	CbGpPWpGaD
Sibutramine—Vomiting—Capecitabine—breast cancer	2.45e-05	7.98e-05	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Epirubicin—breast cancer	2.45e-05	7.97e-05	CcSEcCtD
Sibutramine—Shock—Doxorubicin—breast cancer	2.45e-05	7.96e-05	CcSEcCtD
Sibutramine—Thrombocytopenia—Doxorubicin—breast cancer	2.44e-05	7.93e-05	CcSEcCtD
Sibutramine—Rash—Capecitabine—breast cancer	2.43e-05	7.92e-05	CcSEcCtD
Sibutramine—Insomnia—Epirubicin—breast cancer	2.43e-05	7.91e-05	CcSEcCtD
Sibutramine—Dermatitis—Capecitabine—breast cancer	2.43e-05	7.91e-05	CcSEcCtD
Sibutramine—Tachycardia—Doxorubicin—breast cancer	2.43e-05	7.9e-05	CcSEcCtD
Sibutramine—Headache—Capecitabine—breast cancer	2.42e-05	7.87e-05	CcSEcCtD
Sibutramine—Skin disorder—Doxorubicin—breast cancer	2.42e-05	7.86e-05	CcSEcCtD
Sibutramine—Paraesthesia—Epirubicin—breast cancer	2.41e-05	7.86e-05	CcSEcCtD
Sibutramine—Hyperhidrosis—Doxorubicin—breast cancer	2.4e-05	7.83e-05	CcSEcCtD
Sibutramine—Dyspnoea—Epirubicin—breast cancer	2.4e-05	7.8e-05	CcSEcCtD
Sibutramine—Somnolence—Epirubicin—breast cancer	2.39e-05	7.78e-05	CcSEcCtD
Sibutramine—Anorexia—Doxorubicin—breast cancer	2.37e-05	7.72e-05	CcSEcCtD
Sibutramine—Nausea—Docetaxel—breast cancer	2.37e-05	7.7e-05	CcSEcCtD
Sibutramine—Feeling abnormal—Methotrexate—breast cancer	2.37e-05	7.7e-05	CcSEcCtD
Sibutramine—Dyspepsia—Epirubicin—breast cancer	2.37e-05	7.7e-05	CcSEcCtD
Sibutramine—Gastrointestinal pain—Methotrexate—breast cancer	2.35e-05	7.64e-05	CcSEcCtD
Sibutramine—Decreased appetite—Epirubicin—breast cancer	2.34e-05	7.6e-05	CcSEcCtD
Sibutramine—Hypotension—Doxorubicin—breast cancer	2.32e-05	7.56e-05	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Epirubicin—breast cancer	2.32e-05	7.55e-05	CcSEcCtD
Sibutramine—Pain—Epirubicin—breast cancer	2.3e-05	7.48e-05	CcSEcCtD
Sibutramine—Constipation—Epirubicin—breast cancer	2.3e-05	7.48e-05	CcSEcCtD
Sibutramine—Nausea—Capecitabine—breast cancer	2.29e-05	7.46e-05	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTM1—breast cancer	2.29e-05	0.000391	CbGpPWpGaD
Sibutramine—Urticaria—Methotrexate—breast cancer	2.28e-05	7.43e-05	CcSEcCtD
Sibutramine—Abdominal pain—Methotrexate—breast cancer	2.27e-05	7.39e-05	CcSEcCtD
Sibutramine—Body temperature increased—Methotrexate—breast cancer	2.27e-05	7.39e-05	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.27e-05	7.37e-05	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	2.25e-05	0.000386	CbGpPWpGaD
Sibutramine—Insomnia—Doxorubicin—breast cancer	2.25e-05	7.32e-05	CcSEcCtD
Sibutramine—Paraesthesia—Doxorubicin—breast cancer	2.23e-05	7.27e-05	CcSEcCtD
Sibutramine—Dyspnoea—Doxorubicin—breast cancer	2.22e-05	7.22e-05	CcSEcCtD
Sibutramine—Feeling abnormal—Epirubicin—breast cancer	2.22e-05	7.21e-05	CcSEcCtD
Sibutramine—Somnolence—Doxorubicin—breast cancer	2.21e-05	7.2e-05	CcSEcCtD
Sibutramine—Gastrointestinal pain—Epirubicin—breast cancer	2.2e-05	7.15e-05	CcSEcCtD
Sibutramine—Dyspepsia—Doxorubicin—breast cancer	2.19e-05	7.13e-05	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—CYP1A1—breast cancer	2.17e-05	0.000371	CbGpPWpGaD
Sibutramine—Decreased appetite—Doxorubicin—breast cancer	2.16e-05	7.04e-05	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Doxorubicin—breast cancer	2.15e-05	6.99e-05	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	2.14e-05	0.000366	CbGpPWpGaD
Sibutramine—Urticaria—Epirubicin—breast cancer	2.14e-05	6.95e-05	CcSEcCtD
Sibutramine—Pain—Doxorubicin—breast cancer	2.13e-05	6.92e-05	CcSEcCtD
Sibutramine—Constipation—Doxorubicin—breast cancer	2.13e-05	6.92e-05	CcSEcCtD
Sibutramine—Abdominal pain—Epirubicin—breast cancer	2.13e-05	6.92e-05	CcSEcCtD
Sibutramine—Body temperature increased—Epirubicin—breast cancer	2.13e-05	6.92e-05	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—HRAS—breast cancer	2.12e-05	0.000363	CbGpPWpGaD
Sibutramine—Hypersensitivity—Methotrexate—breast cancer	2.12e-05	6.89e-05	CcSEcCtD
Sibutramine—Asthenia—Methotrexate—breast cancer	2.06e-05	6.71e-05	CcSEcCtD
Sibutramine—Feeling abnormal—Doxorubicin—breast cancer	2.05e-05	6.67e-05	CcSEcCtD
Sibutramine—Gastrointestinal pain—Doxorubicin—breast cancer	2.03e-05	6.62e-05	CcSEcCtD
Sibutramine—Pruritus—Methotrexate—breast cancer	2.03e-05	6.61e-05	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ALB—breast cancer	1.98e-05	0.000339	CbGpPWpGaD
Sibutramine—Hypersensitivity—Epirubicin—breast cancer	1.98e-05	6.45e-05	CcSEcCtD
Sibutramine—Urticaria—Doxorubicin—breast cancer	1.98e-05	6.43e-05	CcSEcCtD
Sibutramine—Abdominal pain—Doxorubicin—breast cancer	1.97e-05	6.4e-05	CcSEcCtD
Sibutramine—Body temperature increased—Doxorubicin—breast cancer	1.97e-05	6.4e-05	CcSEcCtD
Sibutramine—Diarrhoea—Methotrexate—breast cancer	1.97e-05	6.4e-05	CcSEcCtD
Sibutramine—Asthenia—Epirubicin—breast cancer	1.93e-05	6.28e-05	CcSEcCtD
Sibutramine—Pruritus—Epirubicin—breast cancer	1.9e-05	6.19e-05	CcSEcCtD
Sibutramine—Dizziness—Methotrexate—breast cancer	1.9e-05	6.18e-05	CcSEcCtD
Sibutramine—Diarrhoea—Epirubicin—breast cancer	1.84e-05	5.99e-05	CcSEcCtD
Sibutramine—Hypersensitivity—Doxorubicin—breast cancer	1.83e-05	5.96e-05	CcSEcCtD
Sibutramine—Vomiting—Methotrexate—breast cancer	1.83e-05	5.94e-05	CcSEcCtD
Sibutramine—Rash—Methotrexate—breast cancer	1.81e-05	5.89e-05	CcSEcCtD
Sibutramine—Dermatitis—Methotrexate—breast cancer	1.81e-05	5.89e-05	CcSEcCtD
Sibutramine—Headache—Methotrexate—breast cancer	1.8e-05	5.86e-05	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—RAF1—breast cancer	1.79e-05	0.000307	CbGpPWpGaD
Sibutramine—Asthenia—Doxorubicin—breast cancer	1.78e-05	5.81e-05	CcSEcCtD
Sibutramine—Dizziness—Epirubicin—breast cancer	1.78e-05	5.78e-05	CcSEcCtD
Sibutramine—Pruritus—Doxorubicin—breast cancer	1.76e-05	5.73e-05	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ALB—breast cancer	1.76e-05	0.000301	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SYNJ2—breast cancer	1.74e-05	0.000298	CbGpPWpGaD
Sibutramine—Vomiting—Epirubicin—breast cancer	1.71e-05	5.56e-05	CcSEcCtD
Sibutramine—Nausea—Methotrexate—breast cancer	1.71e-05	5.55e-05	CcSEcCtD
Sibutramine—Diarrhoea—Doxorubicin—breast cancer	1.7e-05	5.54e-05	CcSEcCtD
Sibutramine—Rash—Epirubicin—breast cancer	1.69e-05	5.52e-05	CcSEcCtD
Sibutramine—Dermatitis—Epirubicin—breast cancer	1.69e-05	5.51e-05	CcSEcCtD
Sibutramine—Headache—Epirubicin—breast cancer	1.68e-05	5.48e-05	CcSEcCtD
Sibutramine—Dizziness—Doxorubicin—breast cancer	1.64e-05	5.35e-05	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—HRAS—breast cancer	1.63e-05	0.000278	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NDUFS3—breast cancer	1.62e-05	0.000277	CbGpPWpGaD
Sibutramine—Nausea—Epirubicin—breast cancer	1.6e-05	5.2e-05	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—RAF1—breast cancer	1.59e-05	0.000272	CbGpPWpGaD
Sibutramine—Vomiting—Doxorubicin—breast cancer	1.58e-05	5.15e-05	CcSEcCtD
Sibutramine—Rash—Doxorubicin—breast cancer	1.57e-05	5.1e-05	CcSEcCtD
Sibutramine—Dermatitis—Doxorubicin—breast cancer	1.57e-05	5.1e-05	CcSEcCtD
Sibutramine—Headache—Doxorubicin—breast cancer	1.56e-05	5.07e-05	CcSEcCtD
Sibutramine—CYP3A4—Metabolism—CHST9—breast cancer	1.52e-05	0.000261	CbGpPWpGaD
Sibutramine—Nausea—Doxorubicin—breast cancer	1.48e-05	4.81e-05	CcSEcCtD
Sibutramine—CYP3A4—Metabolism—COX11—breast cancer	1.44e-05	0.000247	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CDA—breast cancer	1.32e-05	0.000226	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SHMT1—breast cancer	1.32e-05	0.000226	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.27e-05	0.000218	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC2A5—breast cancer	1.27e-05	0.000218	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APRT—breast cancer	1.23e-05	0.00021	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ESRRA—breast cancer	1.15e-05	0.000198	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.15e-05	0.000198	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HADHB—breast cancer	1.09e-05	0.000187	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPI—breast cancer	1.09e-05	0.000187	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.04e-05	0.000179	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.04e-05	0.000179	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—FHL2—breast cancer	1e-05	0.000171	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NME1—breast cancer	1e-05	0.000171	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—UMPS—breast cancer	1e-05	0.000171	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ADSL—breast cancer	1e-05	0.000171	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PHGDH—breast cancer	1e-05	0.000171	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LDHB—breast cancer	9.82e-06	0.000168	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HPSE—breast cancer	9.82e-06	0.000168	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—BRIP1—breast cancer	9.82e-06	0.000168	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HMMR—breast cancer	9.31e-06	0.000159	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCC1—breast cancer	9.31e-06	0.000159	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA3—breast cancer	9.31e-06	0.000159	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARGC1B—breast cancer	9.02e-06	0.000154	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CA9—breast cancer	8.51e-06	0.000146	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA4—breast cancer	8.51e-06	0.000146	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA2—breast cancer	8.3e-06	0.000142	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPX2—breast cancer	8.3e-06	0.000142	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPX4—breast cancer	8.2e-06	0.00014	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SULT1A1—breast cancer	8.2e-06	0.00014	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA1—breast cancer	8.01e-06	0.000137	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—IDH1—breast cancer	8.01e-06	0.000137	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NAT2—breast cancer	7.92e-06	0.000136	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—DPYD—breast cancer	6.94e-06	0.000119	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MED12—breast cancer	6.94e-06	0.000119	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDOA—breast cancer	6.83e-06	0.000117	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NCOA3—breast cancer	6.63e-06	0.000114	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC2A2—breast cancer	6.59e-06	0.000113	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCG2—breast cancer	6.45e-06	0.00011	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CPT1A—breast cancer	6.45e-06	0.00011	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MTR—breast cancer	6.45e-06	0.00011	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HPGDS—breast cancer	6.33e-06	0.000108	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HBA1—breast cancer	6.29e-06	0.000108	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ACHE—breast cancer	6.14e-06	0.000105	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTT1—breast cancer	6.14e-06	0.000105	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP17A1—breast cancer	5.81e-06	9.95e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ENO1—breast cancer	5.75e-06	9.85e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS1—breast cancer	5.75e-06	9.85e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP2D6—breast cancer	5.64e-06	9.66e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NCOA2—breast cancer	5.54e-06	9.48e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—FASN—breast cancer	5.37e-06	9.19e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—BCHE—breast cancer	5.35e-06	9.15e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC5A5—breast cancer	5.28e-06	9.04e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NQO1—breast cancer	5.1e-06	8.73e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC2A1—breast cancer	5.1e-06	8.73e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP1B1—breast cancer	4.89e-06	8.37e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.8e-06	8.21e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NCOA1—breast cancer	4.67e-06	7.99e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—STK11—breast cancer	4.6e-06	7.87e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP19A1—breast cancer	4.6e-06	7.87e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—COMT—breast cancer	4.27e-06	7.32e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTP1—breast cancer	4.25e-06	7.28e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HMOX1—breast cancer	4.2e-06	7.18e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ITPR1—breast cancer	4.19e-06	7.17e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCB1—breast cancer	4.03e-06	6.89e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—TYMS—breast cancer	3.96e-06	6.77e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTM1—breast cancer	3.91e-06	6.69e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.91e-06	6.69e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NCOR1—breast cancer	3.91e-06	6.69e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPX1—breast cancer	3.74e-06	6.41e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP1A1—breast cancer	3.71e-06	6.34e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ERCC2—breast cancer	3.68e-06	6.29e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MTHFR—breast cancer	3.46e-06	5.92e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CAV1—breast cancer	3.19e-06	5.46e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CG—breast cancer	2.9e-06	4.97e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CD—breast cancer	2.55e-06	4.37e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALB—breast cancer	2.52e-06	4.31e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NOS3—breast cancer	2.41e-06	4.13e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CB—breast cancer	2.22e-06	3.81e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS2—breast cancer	2.2e-06	3.77e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTEN—breast cancer	1.92e-06	3.29e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.36e-06	2.32e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AKT1—breast cancer	1.11e-06	1.9e-05	CbGpPWpGaD
